The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib:

Rationale:Fibrosis leads to failure of the skin, lungs, and other organs in systemic sclerosis; accounts for substantial morbidity and mortality; and lacks effective therapy. Myofibroblast activati...